Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ventas, Inc. Director's Dealing 2014

Nov 28, 2014

30143_dirs_2014-11-28_cd61dcca-3edd-41fb-9852-0fc03b6ad1f7.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VENTAS INC (VTR)
CIK: 0000740260
Period of Report: 2014-11-25

Reporting Person: CAFARO DEBRA A (Director, Chairman and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-25 Common Stock M 47618 $41.54 Acquired 569704 Direct
2014-11-25 Common Stock S 47618 $70.1156 Disposed 522086 Direct
2014-11-25 Common Stock M 95236 $41.54 Acquired 100236 Indirect
2014-11-25 Common Stock S 95236 $70.1156 Disposed 5000 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-11-25 Stock Option (Right to Buy) $41.54 M 47618 Disposed 2018-01-22 Common Stock (47618.0) Direct
2014-11-25 Stock Option (Right to Buy) $41.54 M 95236 Disposed 2018-01-22 Common Stock (95236.0) Indirect

Footnotes

F1: On November 25, 2014, the Reporting Person transmitted to the SEC a Form 144 covering the sale of the Issuer's common stock reported in Table I. The shares are being sold pursuant to a written non-discretionary 10b5-1(c) sales plan dated October 2, 2014 entered into by the Reporting Person. The price reported in column 4 is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $70.00 to $70.2050, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1).

F2: On November 25, 2014, The Debra A. Cafaro Insurance Trust (the "Trust")(of which Reporting Person's spousce is the trustee) transmitted to the Securities and Exchange Commission (the "SEC") a Form 144 covering the sale of the Issuer's common stock reported in Table I. The shares are being sold pursuant to a written non-discretionary 10b5-1(c) sales plan dated October 2, 2014 entered into by the Trust. The price reported in column 4 is a weighted average price. These shares were sold by the Trust in multiple transactions at prices ranging from $70.00 to $70.2050, inclusive. The Trust undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).

F3: Reporting Person disclaims beneficial ownership of these 5,000 shares except to the extent of the Reporting Person's pecuniary interest in the shares.

F4: These options were part of a previously reported grant of 428,560 on January 22, 2008 by the Issuer to the Reporting Person (a portion of which was subsequently gifted to the Trust) that vested in three equal annual installments beginning on January 22, 2008.

F5: As of November 25, 2014, Reporting Person owns directly and indirectly by trust options to purchase an aggregate of 1,360,000 shares of Issuer's common stock.